Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
Abstract Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drug...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2e2eb22efc4463c908cf0ac908341c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a2e2eb22efc4463c908cf0ac908341c3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a2e2eb22efc4463c908cf0ac908341c32021-12-02T12:32:31ZNovel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation10.1038/s41598-017-07612-y2045-2322https://doaj.org/article/a2e2eb22efc4463c908cf0ac908341c32017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07612-yhttps://doaj.org/toc/2045-2322Abstract Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (BHO2 and BHO3), have better anti-giardiasic activity than omeprazole in concentrations around 120–130 µM, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives.B. Hernández-OchoaG. Navarrete-VázquezC. Nava-ZuazoA. Castillo-VillanuevaS. T. MéndezA. Torres-ArroyoS. Gómez-ManzoJ. Marcial-QuinoM. Ponce-MacotelaY. Rufino-GonzálezM. Martínez-GordilloG. Palencia-HernándezN. Esturau-EscofetE. Calderon-JaimesJ. Oria-HernándezH. Reyes-VivasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q B. Hernández-Ochoa G. Navarrete-Vázquez C. Nava-Zuazo A. Castillo-Villanueva S. T. Méndez A. Torres-Arroyo S. Gómez-Manzo J. Marcial-Quino M. Ponce-Macotela Y. Rufino-González M. Martínez-Gordillo G. Palencia-Hernández N. Esturau-Escofet E. Calderon-Jaimes J. Oria-Hernández H. Reyes-Vivas Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
description |
Abstract Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (BHO2 and BHO3), have better anti-giardiasic activity than omeprazole in concentrations around 120–130 µM, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives. |
format |
article |
author |
B. Hernández-Ochoa G. Navarrete-Vázquez C. Nava-Zuazo A. Castillo-Villanueva S. T. Méndez A. Torres-Arroyo S. Gómez-Manzo J. Marcial-Quino M. Ponce-Macotela Y. Rufino-González M. Martínez-Gordillo G. Palencia-Hernández N. Esturau-Escofet E. Calderon-Jaimes J. Oria-Hernández H. Reyes-Vivas |
author_facet |
B. Hernández-Ochoa G. Navarrete-Vázquez C. Nava-Zuazo A. Castillo-Villanueva S. T. Méndez A. Torres-Arroyo S. Gómez-Manzo J. Marcial-Quino M. Ponce-Macotela Y. Rufino-González M. Martínez-Gordillo G. Palencia-Hernández N. Esturau-Escofet E. Calderon-Jaimes J. Oria-Hernández H. Reyes-Vivas |
author_sort |
B. Hernández-Ochoa |
title |
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
title_short |
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
title_full |
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
title_fullStr |
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
title_full_unstemmed |
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
title_sort |
novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/a2e2eb22efc4463c908cf0ac908341c3 |
work_keys_str_mv |
AT bhernandezochoa novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT gnavarretevazquez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT cnavazuazo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT acastillovillanueva novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT stmendez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT atorresarroyo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT sgomezmanzo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT jmarcialquino novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT mponcemacotela novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT yrufinogonzalez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT mmartinezgordillo novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT gpalenciahernandez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT nesturauescofet novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT ecalderonjaimes novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT joriahernandez novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation AT hreyesvivas novelgiardicidalcompoundsbearingprotonpumpinhibitorscaffoldproceedingthroughtriosephosphateisomeraseinactivation |
_version_ |
1718394052195385344 |